Topic listResearch writingBiological & life sciences

Immunology dissertation topics: immunotherapy, microbiome, immunosenescence and vaccine design

Ten broad immunology ideas, checked and rebuilt into sixteen topics in five themes, each turned into a question one project can answer, with the design it would need and why it matters now.

What you will learn

  • Identify five active areas of immunology where a master's or doctoral project can add evidence
  • Turn a broad label such as "immunosenescence" into a measurable research question
  • Choose between in vitro, animal, human cohort and computational designs for an immunology topic
  • Explain why reproducibility problems shape how immunology projects should be designed
  • Test a topic for feasibility against samples, models, ethics and budget

What you will unlearn

  • A topic is a heading such as "cancer immunotherapy".A topic becomes researchable when it names a cell type or pathway, a model or population, an outcome and a comparison.
  • A striking mouse result is a safe foundation for a thesis.Many preclinical findings fail to replicate, so plan to confirm the key result before building on it.
  • Microbiome differences between groups show that microbes cause disease.Associations are often inconsistent across studies; causal claims need experimental or longitudinal designs.

Skills you will practise

  • Topic scoping
  • Choosing model systems
  • Immunophenotyping design
  • Cohort and biobank use
  • Reproducible experimental design
  • Ethics planning

How to use this list

This list is for master's and doctoral researchers in immunology and related fields who need a project topic.

Treat every row as a starting point. Before you commit, check what samples, animal models, cell lines, flow cytometry or sequencing capacity your laboratory can provide, and search for studies from the last three years. Related pages: biology dissertation titles, CRISPR gene editing topics and a critical review of lactylation in cancer.

Recent research ideas on immunology
Figure 1. Research ideas in immunology.

Theme 1: Tumour immunology and immunotherapy

Immune checkpoint inhibitors and engineered T-cell therapies have changed cancer treatment, but many patients do not respond, and the tumour microenvironment is one reason. Tumour metabolism is part of that environment: lactic acid produced by tumour cells can polarise tumour-associated macrophages towards a function that supports tumour growth (Colegio et al., 2014), and lactate-derived protein modification (lactylation) is now studied as a link between metabolism and immune evasion (Chen, J., et al., 2025). In pancreatic cancer, for example, histone lactylation has been reported to increase CXCL1 expression, neutrophil infiltration and immune escape (Zhang, P., et al., 2026).

Theme 1 topics: tumour immunology and immunotherapy
TopicPossible research questionLikely design and dataWhy it matters now
Lactate and macrophage functionDoes blocking lactate export from tumour cells shift macrophages away from a tumour-supporting phenotype in co-culture?Co-culture of tumour cells and macrophages; flow cytometry and gene expression; pharmacological or genetic inhibitionLinks tumour metabolism to a cell type that shapes immunotherapy response
Neutrophils and immune escapeDoes reducing CXCL1 signalling restore T-cell infiltration in a mouse model of pancreatic cancer?Syngeneic mouse model; immunohistochemistry and flow cytometry; ARRIVE-compliant designPancreatic cancer responds poorly to current immunotherapy
Predicting checkpoint inhibitor responseDo circulating immune cell profiles before treatment predict response to checkpoint inhibitors in one cancer type?Prospective or biobank cohort; flow cytometry or single-cell data; pre-registered prediction modelResponse is hard to predict, and non-responders face toxicity without benefit
Reproducibility of a key findingDoes a published immunotherapy-enhancing effect replicate in an independent model and laboratory?Pre-registered replication with power calculation and blinded assessmentMany preclinical cancer findings have failed to replicate

The last row deserves serious consideration. When one company tried to confirm landmark preclinical cancer studies, most could not be reproduced (Begley & Ellis, 2012), and a well-designed replication can be a strong doctoral contribution.

Theme 2: The microbiome and immunity

The gut microbiome trains and regulates the immune system, and microbial communities differ between health and disease. Early work showed that the gut microbiome of obese mice had an increased capacity to harvest energy and that this trait could be transferred to germ-free mice (Turnbaugh et al., 2006). Yet a reanalysis of human datasets found that a simple taxonomic signature of obesity was not consistent across studies (Finucane et al., 2014). That tension, between striking experimental effects and inconsistent human associations, defines the best microbiome-immunity topics.

Theme 2 topics: the microbiome and immunity
TopicPossible research questionLikely design and dataWhy it matters now
Microbial metabolites and regulatory T cellsDo short-chain fatty acids produced by gut bacteria change the balance of regulatory and inflammatory T cells in a colitis model?Mouse model with dietary or bacterial intervention; flow cytometry; metabolite measurementMechanisms are needed to move beyond association
Microbiome and vaccine responseIs baseline gut microbiome composition associated with antibody response to a routine vaccine in adults?Prospective cohort; stool sequencing; antibody titres; adjustment for age and antibiotic useVaccine responses vary widely between individuals
Reproducibility of microbiome signaturesDo reported microbiome signatures of an autoimmune disease replicate across public datasets?Secondary analysis of public sequencing data with harmonised processingInconsistent signatures have weakened earlier claims

Theme 3: Immunosenescence and inflammaging

The immune system changes with age: responses to new infections and vaccines weaken, and low-grade chronic inflammation, often called inflammaging, is linked to cardiovascular disease, diabetes and neurodegeneration. Measuring biological age is now a research field of its own, from DNA methylation clocks (Horvath & Raj, 2018) to a broader effort to validate biomarkers of ageing for use in studies (Moqri et al., 2024). Immune measures are natural candidates for such work.

Theme 3 topics: immunosenescence and inflammaging
TopicPossible research questionLikely design and dataWhy it matters now
Immune ageing and epigenetic ageAre T-cell subset proportions associated with epigenetic age acceleration in older adults, independent of chronological age?Cross-sectional or cohort study; flow cytometry; DNA methylation dataConnects immune ageing to validated ageing biomarkers
Inflammaging and cardiometabolic riskDo inflammatory markers add to standard risk scores in predicting cardiovascular events in older adults?Secondary analysis of a cohort or biobank; survival modelsTests whether inflammation measures are clinically useful
Vaccine response in older adultsWhich immune features before vaccination predict a weak antibody response to influenza vaccine in people over 65?Prospective cohort; immunophenotyping; antibody titresCould guide who needs enhanced vaccines

Theme 4: Infection immunology and vaccines

Tuberculosis remains a major global health problem, and the choice of model system shapes what TB immunology can learn. Each model, from cell culture to animals, captures some features of human infection and misses others (Nangpal et al., 2025). Bioengineered models are one response: magnetic bioprinted granulomas have been used to study the immune response of cattle to Mycobacterium bovis (Krueger et al., 2025). Vaccine research also extends beyond the laboratory, for example to how limited vaccine supplies can be distributed efficiently and fairly (Enayati & Özaltın, 2020).

Theme 4 topics: infection immunology and vaccines
TopicPossible research questionLikely design and dataWhy it matters now
3D granuloma modelsDoes a 3D granuloma model reproduce the cytokine profile of human TB granulomas better than 2D macrophage culture?In vitro comparison of 2D and 3D models; cytokine and gene expression assays; containment-level facilitiesBetter models could reduce reliance on animals
Durability of vaccine immunityHow quickly do antibody and memory T-cell responses wane after a respiratory virus vaccine, and do they differ by age?Longitudinal cohort with repeated blood samplesInforms booster timing beyond the pandemic period
Equitable vaccine allocationHow do equity constraints change the optimal allocation of a limited influenza vaccine supply across regions?Mathematical optimisation or simulation with public surveillance dataCombines immunology with operations research and policy

Theme 5: Autoimmunity and gene editing

Autoimmune diseases arise when tolerance fails, and new therapies aim to reset the immune system rather than suppress it broadly. Gene editing underpins several of these approaches. CRISPR-Cas9 was first shown to be a programmable DNA-cutting enzyme in a study of bacterial adaptive immunity (Jinek et al., 2012), and it is now used to engineer immune cells and to model immune disorders in the laboratory.

Theme 5 topics: autoimmunity and gene editing
TopicPossible research questionLikely design and dataWhy it matters now
Gene-edited models of immune disordersDoes knocking out a candidate susceptibility gene in a human T-cell line alter activation and cytokine release?CRISPR knockout in a cell line; activation assays; off-target checksMoves genetic associations towards mechanism
Cell therapy for autoimmunityWhat are the reported efficacy and safety outcomes of engineered T-cell therapies in autoimmune disease so far?Systematic review of early clinical reportsEngineered T-cell therapies are being tested beyond cancer
Regulatory T-cell stabilityUnder what inflammatory conditions do regulatory T cells lose their suppressive function in vitro?Primary human cell culture; flow cytometry; functional suppression assaysRegulatory T-cell therapies depend on stability

How to test a topic before you commit

A useful screen is the FINER test: is the question feasible, interesting, novel, ethical and relevant (Hulley et al., 2013)? In immunology, feasibility usually turns on access to samples, animals and equipment. If your design uses animals, plan it against the ARRIVE 2.0 guidelines from the start, including sample size, randomisation and blinding (Percie du Sert et al., 2020). Decide what your experimental unit is: cells from one donor or one mouse are not independent replicates (Lazic et al., 2018).

Then write the question in one sentence that names the cell type or pathway, the model or population, the outcome and the comparison, and ask your supervisor whether a three- or four-year project can answer it with the resources available. If not, narrow the population, the outcome or the number of models.

Common mistakes

  • Choosing a fashionable area such as immunotherapy without a specific cell type, pathway or outcome.
  • Building a thesis on one unreplicated mouse finding.
  • Treating cells or wells as independent samples, which inflates significance.
  • Underestimating the time needed for ethics approval, biobank access or animal licences.
  • Claiming causation from a cross-sectional microbiome or biomarker association.

Key takeaways

Your next step

Want to apply this to your own study?

  1. 1Tell us your topic, data and deadline
  2. 2A subject mentor reviews your work with you
  3. 3You get a plan and a quote
PhD topic selection

References

  1. Begley, C. G., & Ellis, L. M. (2012). Raise standards for preclinical cancer research. Nature, 483(7391), 531–533. https://doi.org/10.1038/483531a
  2. Chen, J., Huang, Z., Chen, Y., Tian, H., Chai, P., Shen, Y., Yao, Y., Xu, S., Ge, S., & Jia, R. (2025). Lactate and lactylation in cancer. Signal Transduction and Targeted Therapy, 10, Article 38. https://doi.org/10.1038/s41392-024-02082-x
  3. Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., Cline, G. W., Phillips, A. J., & Medzhitov, R. (2014). Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature, 513(7519), 559–563. https://doi.org/10.1038/nature13490
  4. Enayati, S., & Özaltın, O. Y. (2020). Optimal influenza vaccine distribution with equity. European Journal of Operational Research, 283(2), 714–725. https://doi.org/10.1016/j.ejor.2019.11.037
  5. Finucane, M. M., Sharpton, T. J., Laurent, T. J., & Pollard, K. S. (2014). A taxonomic signature of obesity in the microbiome? Getting to the guts of the matter. PLoS ONE, 9(1), e84689. https://doi.org/10.1371/journal.pone.0084689
  6. Horvath, S., & Raj, K. (2018). DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nature Reviews Genetics, 19(6), 371–384. https://doi.org/10.1038/s41576-018-0004-3
  7. Hulley, S. B., Cummings, S. R., Browner, W. S., Grady, D. G., & Newman, T. B. (2013). Designing clinical research (4th ed.). Wolters Kluwer Health/Lippincott Williams & Wilkins. https://search.worldcat.org/title/830019201
  8. Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 337(6096), 816–821. https://doi.org/10.1126/science.1225829
  9. Krueger, G., Meesaragandla, B., Schultze, L., Pape, K., Zedler, U., Stooß, G., Faisal, S., Franzke, K., Barth, S. A., Janke, U., Kaufmann, S. H. E., Corleis, B., Delcea, M., & Dorhoi, A. (2025). Modeling immune responses of cattle to Mycobacterium bovis using magnetic bioprinted granulomas. mSphere, 10(11), Article e00595-25. https://doi.org/10.1128/msphere.00595-25
  10. Lazic, S. E., Clarke-Williams, C. J., & Munafò, M. R. (2018). What exactly is 'N' in cell culture and animal experiments? PLoS Biology, 16(4), e2005282. https://doi.org/10.1371/journal.pbio.2005282
  11. Moqri, M., Herzog, C., Poganik, J. R., Ying, K., Justice, J. N., Belsky, D. W., Higgins-Chen, A. T., Chen, B. H., Cohen, A. A., Fuellen, G., Hägg, S., Marioni, R. E., Widschwendter, M., Fortney, K., Fedichev, P. O., Zhavoronkov, A., Barzilai, N., Lasky-Su, J., Kiel, D. P., . . . Ferrucci, L. (2024). Validation of biomarkers of aging. Nature Medicine, 30(2), 360–372. https://doi.org/10.1038/s41591-023-02784-9
  12. Nangpal, P., Nagpal, N. L., Angrish, N., & Khare, G. (2025). Model systems to study Mycobacterium tuberculosis infections: An overview of scientific potential and impediments. Frontiers in Cellular and Infection Microbiology, 15, Article 1572547. https://doi.org/10.3389/fcimb.2025.1572547
  13. Percie du Sert, N., Hurst, V., Ahluwalia, A., Alam, S., Avey, M. T., Baker, M., Browne, W. J., Clark, A., Cuthill, I. C., Dirnagl, U., Emerson, M., Garner, P., Holgate, S. T., Howells, D. W., Karp, N. A., Lazic, S. E., Lidster, K., MacCallum, C. J., Macleod, M., . . . Würbel, H. (2020). The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biology, 18(7), e3000410. https://doi.org/10.1371/journal.pbio.3000410
  14. Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 444(7122), 1027–1031. https://doi.org/10.1038/nature05414
  15. Zhang, P., Ma, J., Wan, Y., Li, C., Liu, L., He, M., Zhang, N., Ma, Y., Hu, J., Zhao, L., Zhong, Z., Lei, X., Gong, J., Zeng, T., Ma, J., Da, Y., Zhou, Z., Yang, J., Wang, X., Gong, T., & Zhang, C. (2026). Histone lactylation increases CXCL1 expression for neutrophil infiltration and immune escape in pancreatic cancer. Nature Communications, 17, Article 2526. https://doi.org/10.1038/s41467-026-69311-5

How to cite this article

Choose your referencing style, then copy. Check your university's or journal's guide for local variations.

PhD Research Lab Academy. (2023, April 5). Immunology dissertation topics: immunotherapy, microbiome, immunosenescence and vaccine design. PhD Research Lab. https://www.phdassistance.com/blog/recent-research-ideas-on-immunology/

PhD Research Lab Academy. “Immunology Dissertation Topics: Immunotherapy, Microbiome, Immunosenescence and Vaccine Design.” PhD Research Lab, 5 Apr. 2023, www.phdassistance.com/blog/recent-research-ideas-on-immunology. Accessed [access date].

PhD Research Lab Academy (2023) Immunology dissertation topics: immunotherapy, microbiome, immunosenescence and vaccine design. PhD Research Lab. Available at: https://www.phdassistance.com/blog/recent-research-ideas-on-immunology/ (Accessed: [access date]).

PhD Research Lab Academy. “Immunology Dissertation Topics: Immunotherapy, Microbiome, Immunosenescence and Vaccine Design.” PhD Research Lab. April 5, 2023. https://www.phdassistance.com/blog/recent-research-ideas-on-immunology.

PhD Research Lab Academy, ‘Immunology Dissertation Topics: Immunotherapy, Microbiome, Immunosenescence and Vaccine Design’ (PhD Research Lab, 5 April 2023) <https://www.phdassistance.com/blog/recent-research-ideas-on-immunology> accessed [access date].

PhD Research Lab Academy. Immunology dissertation topics: immunotherapy, microbiome, immunosenescence and vaccine design [Internet]. PhD Research Lab; 2023 Apr 5 [cited [access date]]. Available from: https://www.phdassistance.com/blog/recent-research-ideas-on-immunology/

PhD Research Lab Academy, “Immunology dissertation topics: immunotherapy, microbiome, immunosenescence and vaccine design,” PhD Research Lab, Apr. 5, 2023. [Online]. Available: https://www.phdassistance.com/blog/recent-research-ideas-on-immunology. [Accessed: [access date]].

@online{recent_research_ideas_on_immunology_2023,
  author = {{PhD Research Lab Academy}},
  title = {{Immunology dissertation topics: immunotherapy, microbiome, immunosenescence and vaccine design}},
  organization = {PhD Research Lab},
  date = {2023-04-05},
  url = {https://www.phdassistance.com/blog/recent-research-ideas-on-immunology},
  urldate = {[access date]}
}

This article is for learning. Use it to understand the method and cite the original sources above in your own work; do not copy or submit it as your own.

Immunology dissertation topicsNeed help applying it to your study?
PhD topic selection